Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Ribonucleotide reductase R2-targeting antisense oligonucleotides for neoplastic diseases

Jan. 12, 2000

Alfa Wassermann will market and distribute Ligand's oncology products in Italy

Jan. 12, 2000

Canstatin is a potent angiogenesis inhibitor in preclinical models

Jan. 12, 2000

Synthesis and biological activity of new radicicol derivatives presented by Kyowa Hakko

Jan. 11, 2000

Millennium reports discovery of apoptosis-linked proteins

Jan. 11, 2000

ADNF III/ADNP antisense oligonucleotides available for licensing from NIH

Jan. 11, 2000

Thalidomide for therapy of refractory multiple myeloma

Jan. 11, 2000

Depot avorelin produces effective, sustained and safe medical castration in prostate cancer

Jan. 10, 2000

Korean lab focuses on fumagillol derivatives as angiogenesis inhibitors

Jan. 10, 2000

Novel Pfizer compounds useful for hyperproliferative disorders

Jan. 5, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...